SABPA OCLA 2013 Biomedical Forum

  • Topics:

    SABPA OCLA 2013 Biomedical Forum

  • Date/Time:

    4 May 2013 - 4 May 2013 @ 8:00 AM – 4:30 PM

  • Location:

    Crowne Plaza Hotel, 3131 Bristol Street, Costa Mesa, CA 92626

  • Attachment:

  • Share:

The beautiful southern California spring welcomes our SABPA 8th Annual Biomedical Forum on Saturday, May 4th, 2013. This year’s forum will focus on hot topics such as career development, entrepreneurship, compliance issues, and the latest innovations in medical devices and pharmaceutical industries. We have an exciting program with our prestigious speakers from the winner of US National Medal of Science, FDA compliance official, successful entrepreneurs, top scientists/professors, well experienced researchers from Industries, and extremely knowledgeable attorney. I welcome you all join this forum and take this opportunity to learn, share, and network among our entrepreneurs, scientists, engineers, investors, executives, students, and policy makers in order to promote life sciences, biotech, medical device, pharmaceutical, and alliances across the biomedical industry in Southern California and Asian countries.

I would like to take this opportunity to thank the SABPA OCLA committee members for their hard work, our sponsors for their generosity, and your participations to make our forum successful. I would welcome you all get involved and provide supports to SABPA for its future development and growth.

Wish you all enjoy the forum.

Cheers!

Yan-Bo Yang, Ph.D.
President, SABPA OCLA

a:18:{i:0;a:3:{s:12:"time_program";s:12:"8:00-9:00 AM";s:19:"description_program";s:0:"";s:7:"program";s:45:"Registration, Breakfast, Exhibit & Networking";}i:1;a:3:{s:12:"time_program";s:9:"9:00-9:05";s:19:"description_program";s:46:"Yan-Bo Yang, Ph.D.
President, SABPA OCLA";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:9:"9:05-9:10";s:19:"description_program";s:59:"Fred Ouyang, Ph.D. MBA,
Former President, SABPA OCLA";s:7:"program";s:24:"Chairperson of session 1";}i:3;a:3:{s:12:"time_program";s:9:"9:10-9:45";s:19:"description_program";s:133:"Shu Chien, Ph.D.
University Professor of Bioengineering & Medicine and Director of Institute of Engineering in Medicine at UCSD";s:7:"program";s:53:"Life and Science: A Case History and General Thoughts";}i:4;a:3:{s:12:"time_program";s:10:"9:45-10:15";s:19:"description_program";s:104:"Assad Kazeminy, Ph.D.,
President/CEO at Avrio BioPharmaceuticals & Irvine Pharmaceutical Services ";s:7:"program";s:17:"My Path to Irvine";}i:5;a:3:{s:12:"time_program";s:11:"10:15-10:40";s:19:"description_program";s:0:"";s:7:"program";s:39:"Refreshment Break, Exhibit & Networking";}i:6;a:3:{s:12:"time_program";s:11:"10:40-10:45";s:19:"description_program";s:71:"Huaina Li, Ph.D.
Chair, Event Registration Committee, SABPA OCLA";s:7:"program";s:24:"Chairperson of session 2";}i:7;a:3:{s:12:"time_program";s:11:"10:45-11:15";s:19:"description_program";s:71:"David Zhou, Ph.D., Chief Scientist, Second Sight Medical Products, Inc";s:7:"program";s:66:"Artificial Vision for the Blind: Biomedical Engineering Approaches";}i:8;a:3:{s:12:"time_program";s:11:"11:15-11:45";s:19:"description_program";s:184:"Wendy Liu, Ph.D.,
Assistant Professor, Edwards Life Sciences Center for Advanced Cardiovascular Technology, Department of Biomedical Engineering, University of California, Irvine";s:7:"program";s:73:"Engineering Biomaterials to Control the Host Response to Medical Implants";}i:9;a:3:{s:12:"time_program";s:11:"11:45-12:15";s:19:"description_program";s:102:"Tao Wang, Ph.D.
Director, Analytical Sciences,
Pharmaceutical Development, Allergan, Inc.";s:7:"program";s:70:"Strategies in Evaluating, Testing and Controlling Genotoxic Impurities";}i:10;a:3:{s:12:"time_program";s:14:"12:15-12:30 PM";s:19:"description_program";s:66:"Jinsong Ni, Ph.D. Chair,
Fund Raising Committee, SABPA OCLA";s:7:"program";s:21:"Sponsor Appreciations";}i:11;a:3:{s:12:"time_program";s:10:"12:30-2:00";s:19:"description_program";s:0:"";s:7:"program";s:28:"Lunch, Exhibit & Networking";}i:12;a:3:{s:12:"time_program";s:9:"2:00-2:05";s:19:"description_program";s:47:"Yan-Bo Yang, Ph.D.
President, SABPA OCLA";s:7:"program";s:24:"Chairperson of session 3";}i:13;a:3:{s:12:"time_program";s:9:"2:05-2:35";s:19:"description_program";s:123:"Raymond W. Brullo, D.P.M
Fellow, American Professional Wound Care Assoc. FDA, Los Angeles District, Compliance Branch";s:7:"program";s:84:"Compliance Overview & Case Examples, Novel and Emerging Areas, Imports and FDA-China";}i:14;a:3:{s:12:"time_program";s:9:"2:35-3:05";s:19:"description_program";s:84:"Kevin Shao
President of Sino-American Stephanos Medical Device Solutions, LLC ";s:7:"program";s:64:"Medical Device Sourcing in China -- Opportunities and Challenges";}i:15;a:3:{s:12:"time_program";s:9:"3:05-3:35";s:19:"description_program";s:53:"Terry Tullis, J.D., MBA
Partner, Knobbe Martens";s:7:"program";s:41:"Commercialization and Patent Infringement";}i:16;a:3:{s:12:"time_program";s:9:"3:35-3:50";s:19:"description_program";s:100:"Bruce Coleman
Economic Development Director, Economic Development
Dept., City of Murrieta";s:7:"program";s:67:"Understanding of local government support for life science industry";}i:17;a:3:{s:12:"time_program";s:9:"3:50-3:55";s:19:"description_program";s:56:"Ying Zhao,
Founding President, SABPA OCLA Chapter";s:7:"program";s:16:"Closing Remarks:";}}

This registration has now closed.
Please check back for future SABPA OCLA events!

SABPA OCLA
Speaker Title Link
Kevin Shao Medical Device Sourcing in China -- Opportunities and Challenges
Assad Kazeminy My Path to Irvine Pharma
Raymond W. Brullo Compliance Overview & Case Examples, Novel and Emerging Areas, Imports and FDA-China
Tao Wang Strategies in Evaluating, Testing and Controlling Genotoxic Impurities (GTI)
Terry K. Tullis Commercialization and Patent Infringement